Marco Minacori

8PUBLICATIONS
20CO-AUTHORS
PharmacogenomicsNatural products and bioactive compoundsMolecular targetsHorticultural crop improvement (incl. selection and breeding)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 16, 2024
Analysis of Punicalin and Punicalagin Interaction with PDIA3 and PDIA1.

Giorgia Meschiari, Marco Minacori, Sara Fiorini

|Jun 19, 2024
STAT3 Pathways Contribute to β-HCH Interference with Anticancer Tyrosine Kinase Inhibitors.

Sara Fiorini, Elisabetta Rubini, Monia Perugini

|Sep 09, 2023
Protein Disulfide Isomerase A3 (PDIA3): A Pharmacological Target in Glioblastoma?

Giuliano Paglia, Marco Minacori, Giorgia Meschiari

|Mar 29, 2023
Improving Whole Tomato Transformation for Prostate Health: Benign Prostate Hypertrophy as an Exploratory Model.

Pier Giorgio Natali, Mauro Piantelli, Marco Minacori

|Sep 23, 2022
β-Caryophyllene Counteracts Chemoresistance Induced by Cigarette Smoke in Triple-Negative Breast Cancer MDA-MB-468 Cells.

Antonella Di Sotto, Marco Gullì, Marco Minacori

|Jun 24, 2022
Sorafenib Chemosensitization by Caryophyllane Sesquiterpenes in Liver, Biliary, and Pancreatic Cancer Cells: The Role of STAT3/ABC Transporter Axis.

Silvia Di Giacomo, Marco Gullì, Roberta Facchinetti

Pageof 2

Frequent Collaborators

7 joint publications

Margherita Eufemi

5 joint publications

Fabio Altieri

3 joint publications

Giuliano Paglia

3 joint publications

Elisabetta Rubini